Navigation Links
U.S. Demand for Rehabilitation Professionals Grows
Date:9/8/2008

Foundation (NRAF).

More than 6,000 rehabilitation providers and health and human services organizations across the country are helping recognize "the powers of rehabilitation," according to Jim Brogna, NRAF executive director. This year's theme is, "Rehab: The Power to Change Lives."

During rehabilitation awareness week, the foundation, healthcare systems and other groups are expressing support for rehabilitation professionals who provide compassionate support in all areas to help patients improve their quality of life.

http://allsup.com/About-SSDI/SSDI-Guidelines-by-Disability.aspx [Allsup] is observing the National Rehabilitation Awareness Celebration with a limited number of free posters available to hospitals, clinics and other community groups by calling Karen Hercules-Doerr at (800) 854-1418, ext. 5770.

NRAF contact:                  
National Rehabilitation Awareness Foundation   
Jim Brogna                  
(800) 943-6723                  
jbrogn @ allied-services.org
www.nraf-rehabnet.org

Free posters:
Allsup
Karen Hercules-Doerr
(800) 854-1418, ext. 5770   
k.hercules-doerr @ allsupinc.com      
www.allsupcares.com

###

Read the full story at http://www.prweb.com
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. FDA Demands Tougher Warnings on Immunosuppressive Drugs
2. Caregivers Demand Better Patient Care at Eight Bay Area Nursing Homes
3. Tx Xchange Launches Web-Based Solution for Physical Therapy and Rehabilitation Providers to Address Demands of Healthcare Consumerism
4. Hibernation-on-demand drug significantly improves survival after extreme blood loss
5. Latest Research Shows Strong Consumer Demand for Organic Foods
6. Agendia Expands Laboratory Capacity at New Amsterdam Headquarters to Meet Increasing Demand for Services Worldwide
7. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
8. Lance Armstrong Foundation and Demand Media Launch LIVESTRONG.COM
9. St. Joseph Health System Caregivers Demand Foley & Lardner Stop Intimidation, and Waste of Valuable Patient Care Resources
10. European conference addresses increasing demand for EO data
11. Shareholders Demand Philip Morris USA Stop Interfering in Health Policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... For most people, family gath...art of the fun of the holiday season. Not so for t...ven avoid--social situations, reports the December... Boston (Vocus) December 2,...es, and other social activities are part of the fu...
(Date:12/2/2008)...YORK, Dec. 2 SkinnyAndTheCity.com...omen who want to look fabulous and feel their best..., R.D., has assembled the most credited team of ex...and lifestyle and brought them all together on one...ute, relevant information on the market today - al...
(Date:12/2/2008)...NTA, Dec. 2 Ingenious Med (IM) wel... IM, the leader in inpatient practice,management ...r in healthcare,software, revenue management, me... Founder and nine-year CEO, Dr. Steven Liu, is con...ss and development in all sectors, as he steps int...
(Date:12/2/2008)...INGTON, Dec. 2 EIN News...providing in-depth news on brain cancer. , , ...ients are finding out that information is one of t... Responding to the growing demand for accurate in...reening procedures and drugs to treat it, EIN News...
Breaking Medicine News(10 mins):Health News:Easing Social Anxiety During the Holidays: Tips from Harvard Women's Health Watch 2Health News:SkinnyAndTheCity.com Top Experts Create the Ultimate Lifestyle Guide 2Health News:Ingenious Med Hires New CEO to Maintain and Further Expand Company Development 2Health News:EIN News Introduces 'Brain Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2
...ndia is probably much higher than official data sh...am says.// India, which has 5.1 million people wit...cord, announced earlier in 2005 that new infection...in 2004, down from 520,000 in 2003. International...
...can improve exercise capacity and functional abili...n, a serious disease involving high pressure in th...suggests.// According to a report by Reuters, the ...and Journal of Medicine, are based on a study of 2...
...Sciences (AIIMS) proposes to construct a new terti... of the Government to provide land for construct...modern facilities. The Central Arid Zone Research...dealing with arid regions has agreed to provide 10...
...emists at Harvard University, who say that these p...igger could hold the key to oncogenesis,// the pro...ises when an oncoprotien, a protein known to cause... the development of cancer, 'We present the hypoth...
Other Medicine News:
(Date:12/2/2008)... 2 TorreyPines Therapeutics, Inc. ... from a 26 patient Phase II trial evaluating three... dry mouth, in patients with Sjogren,s syndrome. ... significant increase in salivary flow production ...mg, and 20 mg. These doses were safe and well tole...
(Date:12/2/2008)...PRNewswire/ -- Horizon Therapeutics, Inc., a,priv...ced that two pivotal,Phase 3 trials evaluating it...,met all primary endpoints. HZT-501, a novel, pro...g ibuprofen and famotidine, demonstrated a,statis...non-steroidal,anti-inflammatory drug (NSAID)-indu...
(Date:12/2/2008)... Micromet, Inc. (Nasdaq: ...ovel, proprietary antibodies for the treatment of ...y announced that it has entered into an agreement ...(CEFF) with Kingsbridge Capital Limited, a private...nt, Kingsbridge has committed to provide up to $75...
(Date:12/1/2008)...swire-USNewswire/ -- New research has found that t... tomography (CT) scanner in an emergency room can ...s who receive a potentially life-saving treatment....dical Center (NSMC)-Salem Hospital in Salem, Mass.... the Radiological Society of North America (RSNA)....
Breaking Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3NLPC Criticizes Obamas Choice of Eric Holder for Attorney General Because of Role in Health Care Task Force Cover Up 30055 1NLPC Criticizes Obamas Choice of Eric Holder for Attorney General Because of Role in Health Care Task Force Cover Up 30055 2Cancer Drugs May Treat Type 1 Diabetes 30051 1Cancer Drugs May Treat Type 1 Diabetes 30051 2Cold Spring Harbor science teams identify 13 new tumor suppressor genes in liver cancer 30049 1Cold Spring Harbor science teams identify 13 new tumor suppressor genes in liver cancer 30049 2Cold Spring Harbor science teams identify 13 new tumor suppressor genes in liver cancer 30049 3Cold Spring Harbor science teams identify 13 new tumor suppressor genes in liver cancer 30049 4Blue Cross Blue Shield of Michigan Calls for Attorney General to Support Stronger Regulation of Commercial Insurers 3B Protections for Consumers 3B an 30047 1Blue Cross Blue Shield of Michigan Calls for Attorney General to Support Stronger Regulation of Commercial Insurers 3B Protections for Consumers 3B an 30047 2
...SIGA Technologies, Inc.,(NASDAQ: SIGA) announced t...guinea pig trial of its lead Lassa fever virus dru...ty Level 4 conditions at,the U.S. Army Medical Res...by Dr. Kathleen Cashman under the supervision of D...hemorrhagic fever,viruses at USAMRIID for over 12 ...
... data on leading,drug-eluting stent portfolio, NAT... Boston,Scientific Corporation today announced the...announcements at the annual Paris,Course on Revasc...,to 25 in Barcelona, Spain. , "We will be announci...d registries, adding to the knowledge base for tre...
Other Medicine Technology:SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 2SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 3SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 4Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5
...se ECG Systems offer clinical features to meet any...e functionality for paperless storage. Flexible, a...PCE Exercise ECG software turns any computer into ...y to connect with leading EMR systems, the family ...
The Quinton Q-Stress Cardiac Stress Monitor combines Quinton algorithms, unique baseline wander and muscle artifact filters, and 8000 samples per second to provide the highest ECG fidelity in the ind
The CASE 8000 is one of the first, true point-of-care clinical information systems for the exercise environment. By combining the accuracy of our premiere exercise ECG system with the information acc
...cise stress system, the Quest, combines innovative...ic capabilities. Combined with a 15" color monitor...e screen to program or select specific functions. ..., highlighting the step usually taken next. No mor...
Medicine Products: